Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Torrent Pharmaceuticals Ltd. M&A Activity 2026

Mar 24, 2026

61979_rns_2026-03-24_fc04a156-d03d-48fd-a40b-d4d7e1522ef3.pdf

M&A Activity

Open in viewer

Opens in your device viewer

==> picture [456 x 79] intentionally omitted <==

24[th] March, 2026

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1[st] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001

(BSE Scrip Code: 500420)

Mumbai – 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Intimation under Regulation 30 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

In continuation to our earlier intimation dated 29[th] June, 2025, regarding the proposed amalgamation of J.B. Chemicals & Pharmaceuticals Limited (“Transferor Company”) with Torrent Pharmaceuticals Limited (“Transferee Company” or “Company”), pursuant to a Scheme of Amalgamation, we would like to inform you that the Hon’ble National Company Law Tribunal, Ahmedabad Bench has uploaded the Order on its website https://nclt.gov.in/ on 23[rd] March, 2026 towards the first motion application filed in this respect.

The above is for your information and records.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

CHINTAN Digitally signed by CHINTAN M TRIVEDI M TRIVEDI Date: 2026.03.24 18:55:32 +05'30' CHINTAN TRIVEDI COMPANY SECRETARY

==> picture [456 x 42] intentionally omitted <==

==> picture [456 x 43] intentionally omitted <==

Email – [email protected]